Uipath is trading 13.57% down at $15.77 after releasing second-quarter fiscal 2027 results on September 3, 2026.
- Revenue of $410 million and ARR of $1.938 billion both exceeded expectations, and full-year guidance was raised to $1.789-$1.794 billion.
- However, the company also announced a leadership reset, including new CFO, and disclosed a Rule 10b5-1 trading plan for CEO Daniel Dines to sell up to 5,000,000 Class A shares.
- Investors appear to be reacting negatively to these developments, overshadowing the positive financial performance.